mRNA Vaccines
Ideology Over Evidence: RFK Jr. Just Set Vaccine Science Back a Decade
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-25-NI-05Aug 06, 2025
Oral RNA
Unlocking Oral RNA Therapeutics: Overcoming Barriers to Gut-Stable Delivery
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-08Jul 18, 2025
xRNA
Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAO-02-25-CL-11Feb 13, 2025
RNA
Enabling Cost-Effective, Rapid Access to RNA Vaccines and Therapeutics with Enzymatically Generated z- dbDNA
Lisa Caproni
Touchlight
PAO-01-25-CL-08Feb 10, 2025
DPX
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a Market Projected to Grow to USD$48,000,000,000 by 2030
BioVaxys Technology Corp
PR-01-25-NI-20Jan 17, 2025